News for NANOVIRICIDES, INC. (NNVC)

News for NANOVIRICIDES, INC.
Date Headline
May 22, 2018 07:00 AM NanoViricides Files Quarterly Report for Period Ending March 31, 2018; Company Has Over A Year's Worth of Cash in Hand, and It Is Scaling Up Production of Certain Herpecide Program Drug Candidates
May 22, 2018 05:02 AM NanoViricides: Fiscal 3Q Earnings Snapshot
Apr 09, 2018 07:00 AM NanoViricides Reports Good Safety Profile of Topical Dermal Drug Candidates; Dr. Diwan, President, Will Present at the MicroCap Conference in New York City Today
Mar 19, 2018 11:12 AM NanoViricides Drug Candidates to be Tested in Animal Models of Dermal, Ocular and Genital Herpes Virus Infection at the University of Wisconsin
Mar 05, 2018 06:19 PM Is NanoViricides Inc’s (NYSEMKT:NNVC) CEO Paid Enough Relative To Peers?
Feb 26, 2018 07:40 AM Blog Exposure - Shire Gets BLA and Priority Review Status from FDA for Lanadelumab for the Prevention of HAE Attacks
Feb 21, 2018 07:25 AM NanoViricides reports 2Q loss
Feb 21, 2018 07:00 AM NanoViricides Files Quarterly Report for Period Ending December 31, 2017
Feb 14, 2018 02:49 PM How Does NanoViricides Inc (NYSEMKT:NNVC) Affect Your Portfolio Returns?
Feb 12, 2018 08:56 AM Who Are The Largest Shareholders In NanoViricides Inc (NYSEMKT:NNVC)?